日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Functional, biochemical, and clinical characterization of natural mutations affecting arginine residues in the heparin‐binding site of antithrombin

对影响抗凝血酶肝素结合位点精氨酸残基的天然突变进行功能、生化和临床表征

Horn, Heike; Jurinovic, Vindi; Leich, Ellen; Kalmbach, Sabrina; Bausinger, Julia; Staiger, Annette M; Kurz, Katrin S; Möller, Peter; Bernd, Heinz-Wolfram; Feller, Alfred C; Koch, Karoline; Klapper, Wolfram; Stein, Harald; Hansmann, Martin-Leo; Hartmann, Sylvia; Scheubeck, Gabriel; Dreyling, Martin; Hiddemann, Wolfgang; Herfarth, Klaus; Engelhard, Marianne; Rosenwald, Andreas; Hoster, Eva; Ott, German; Cifuentes‐Riquelme, Rosa; de la Morena‐Barrio, María Eugenia; Miñano, Antonia; Garrido‐Rodríguez, Pedro; Velasco, Francisco; Rojo‐Carrillo, Juan José; López‐Correas, Paloma; Zaragoza‐Huesca, David; Padilla, José; Lozano, María Luisa; Bravo‐Pérez, Carlos; Corral, Javier

New Mathematical Model for Correlation Between Tensile Elastic Modulus and Shore "A" and "00" Hardness for Flexible Polymers

柔性聚合物拉伸弹性模量与邵氏A和00硬度相关性的新数学模型

Hoster, Josip; Šimunić, Nikola; Kostadin, Tihana; Vojnović, Bruno

Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study

LYSA 研究通过对 1280 例参与临床试验的套细胞淋巴瘤患者进行分析,验证了 POD24 作为套细胞淋巴瘤早期预后不良的可靠临床指标的有效性。

Sarkozy, Clémentine; Chartier, Loïc; Ribrag, Vincent; Gressin, Remy; Geisler, Christian H; Kluin-Nelemans, Hanneke C; Thieblemont, Catherine; Morschhauser, Franck; Lemonnier, François; Safar, Violaine; Tessoulin, Benoît; Oberic, Lucie; Damaj, Ghandi; Ghesquières, Hervé; Bouabdallah, Krimo; Casasnovas, René Olivier; Houot, Roch; Klapper, Wolfram; Burroni, Barbara; Pott, Christiane; Delfau-Larue, Marie-Hélène; Macintyre, Elizabeth; Callanan, Mary; Jerkeman, Mats; Unterhalt, Michael; Hoster, Eva; Dreyling, Martin; Le Gouill, Steven; Hermine, Olivier; Cheminant, Morgane

Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance

德国淋巴瘤联盟开展的一项II期研究结果显示,伊布替尼联合奥妥珠单抗治疗未经化疗的晚期滤泡性淋巴瘤疗效显著。

Schmidt, Christian; Scheubeck, Gabriel; Jurinovic, Vindi; Sökler, Martin; Forstpointner, Roswitha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Graeven, Ullrich; Marks, Reinhard; Hänel, Mathias; Liersch, Rüdiger; Dürig, Jan; Pott, Christiane; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang

Erratum to: "Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance"

更正:“伊布替尼和奥妥珠单抗联合治疗未经治疗的晚期滤泡性淋巴瘤:德国淋巴瘤联盟 II 期研究的结果”

Schmidt, Christian; Scheubeck, Gabriel; Jurinovic, Vindi; Sökler, Martin; Forstpointner, Roswitha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Graeven, Ullrich; Marks, Reinhard; Hänel, Mathias; Liersch, Rüdiger; Dürig, Jan; Pott, Christiane; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang

The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment

MCL老年患者III期试验方案:一项国际性、随机、开放标签的II期临床试验,旨在研究维奈托克、伊布替尼和利妥昔单抗联合用药或苯达莫司汀、伊布替尼和利妥昔单抗联合用药治疗不适合接受高剂量治疗的初治套细胞淋巴瘤患者的疗效。

Herold, Stephanie; Schmidt, Christian; Visco, Carlo; Tilch, Marie-Kristin; Ohler, Anke; Unterhalt, Michael; Hoster, Eva; Hoenig, Elisabeth; Singer, Susanne; Tucci, Alessandra; Pott, Christiane; Ladetto, Marco; Hess, Georg; Dreyling, Martin

The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network

在复发或难治性套细胞淋巴瘤中,利妥昔单抗、大剂量阿糖胞苷和地塞米松联合硼替佐米治疗——欧洲套细胞淋巴瘤网络的一项随机、开放标签III期试验

Fischer, Luca; Jiang, Linmiao; Dürig, Jan; Schmidt, Christian; Stilgenbauer, Stephan; Bouabdallah, Krimo; Solal-Celigny, Philippe; Scholz, Christian W; Feugier, Pierre; de Wit, Maike; Trappe, Ralf Ulrich; Hallek, Michael; Graeven, Ullrich; Hänel, Mathias; Hoffmann, Martin; Delwail, Vincent; Macro, Margaret; Greiner, Jochen; Giagounidis, Aristoteles A N; Dargel, Beate; Durot, Eric; Foussard, Charles; Silkenstedt, Elisabeth; Weigert, Oliver; Pott, Christiane; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva; Ribrag, Vincent; Dreyling, Martin

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

欧盟患者接受 CD19 CAR-T 治疗复发/难治性大 B 细胞淋巴瘤的疗效劣于美国患者:与肿瘤负荷、全身炎症、桥接治疗利用率和 CAR-T 产品使用情况的差异相关

Bücklein, Veit; Perez, Ariel; Rejeski, Kai; Iacoboni, Gloria; Jurinovic, Vindi; Holtick, Udo; Penack, Olaf; Kharboutli, Soraya; Blumenberg, Viktoria; Ackermann, Josephine; Frölich, Lisa; Johnson, Grace; Patel, Kedar; Arciola, Brian; Mhaskar, Rahul; Wood, Anthony; Schmidt, Christian; Albanyan, Omar; Gödel, Philipp; Hoster, Eva; Bullinger, Lars; Mackensen, Andreas; Locke, Frederick; von Bergwelt, Michael; Barba, Pere; Subklewe, Marion; Jain, Michael D

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment

遗传和微环境特征无法区分滤泡性淋巴瘤患者需要立即治疗还是延迟治疗。

Stevens, Wendy B C; Los-de Vries, G Tjitske; Langois-Jacques, Carole; Clear, Andrew J; Stathi, Phylicia; Sander, Birgitta; Rosenwald, Andreas; Calaminici, Maria; Hoster, Eva; Hiddemann, Wolfgang; Gaulard, Philippe; Salles, Gilles; Klapper, Wolfram; Xerri, Luc; Burton, Catherine; Tooze, Reuben M; Smith, Alexandra G; Buske, Christian; Scott, David W; Natkunam, Yasodha; Advani, Ranjana; Sehn, Laurie H; Raemaekers, John; Gribben, John; Lockmer, Sandra; Kimby, Eva; Kersten, Marie José; Maucort-Boulch, Delphine; Ylstra, Bauke; van Dijk, Erik; de Jong, Daphne

The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma-a pooled trials analysis

利妥昔单抗联合化疗可提高套细胞淋巴瘤患者的总生存期——一项汇总试验分析

Fischer, Luca; Jiang, Linmiao; Bittenbring, Joerg Thomas; Huebel, Kai; Schmidt, Christian; Duell, Johannes; Metzner, Bernd; Krauter, Juergen; Glass, Bertram; Huettmann, Andreas; Schaefer-Eckart, Kerstin; Silkenstedt, Elisabeth; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin; Hoster, Eva